Literature DB >> 2703842

Absence of central functional cholinergic deficits in myasthenia gravis.

S W Lewis1, M A Ron, J Newsom-Davis.   

Abstract

Sporadic reports have suggested central involvement in myasthenia gravis, a disorder in which there is an antibody-mediated loss of peripheral nicotinic acetylcholine receptors. Five patients with symptomatic myasthenia gravis performed an auditory vigilance test of ability to direct and sustain attention, presumed to reflect central cholinergic function. No deficits were found, either in comparison with the same subject's performance when muscle strength had improved after plasma exchange, or compared with that of healthy controls. The results thus failed to substantiate reports of functionally significant central cholinergic deficits in myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703842      PMCID: PMC1032516          DOI: 10.1136/jnnp.52.2.258

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Electroencephalographic findings in myasthenia gravis. 180 EEG recordings of 109 patients.

Authors:  E Hokkanen; E Toivakka
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

3.  The immotile-cilia syndrome. A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility.

Authors:  R Eliasson; B Mossberg; P Camner; B A Afzelius
Journal:  N Engl J Med       Date:  1977-07-07       Impact factor: 91.245

4.  Central nervous-system involvement in experimental autoimmune myasthenia gravis.

Authors:  B W Fulpius; A Fontana; S Cuénoud
Journal:  Lancet       Date:  1977-08-13       Impact factor: 79.321

5.  Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis.

Authors:  A K Lefvert; R Pirskanen
Journal:  Lancet       Date:  1977-08-13       Impact factor: 79.321

6.  Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test.

Authors:  H E Nelson; A O'Connell
Journal:  Cortex       Date:  1978-06       Impact factor: 4.027

7.  Acetylcholine-receptor antibody in cerebrospinal fluid.

Authors:  J C Keesey; W W Tourtellotte; C Herrmann; J M Andrews; J Lindstrom
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

8.  Human serial learning: enhancement with arecholine and choline impairment with scopolamine.

Authors:  N Sitaram; H Weingartner; J C Gillin
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

9.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors:  J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

10.  Inappropriate antihypertensive therapy in the elderly.

Authors:  G Jackson; T A Pierscianowski; W Mahon; J Condon
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

View more
  5 in total

1.  [Intelligence, attention, and memory in patients with myasthenia gravis].

Authors:  R Feldmann; R Kiefer; U Wiegard; S Evers; J Weglage
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

2.  Brain stem auditory evoked potentials reflect central nervous system involvement in myasthenia gravis.

Authors:  R Jech; E Růzicka
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

3.  Neuropsychological assessment in myasthenia gravis.

Authors:  Emilia J Sitek; Małgorzata M Bilińska; Dariusz Wieczorek; Walenty M Nyka
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307

Review 4.  Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis.

Authors:  Zhifeng Mao; Junjie Yin; Zhengqi Lu; Xueqiang Hu
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

5.  Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.

Authors:  Antonia Kaltsatou; Dimitris Fotiou; Dimitris Tsiptsios; Anastasios Orologas
Journal:  BBA Clin       Date:  2015-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.